Brief: China Pharma Holdings Q3 Loss Per Share $0.02
15/11/2019 14:53
China Pharma Holdings Inc CPHI.A :
* CHINA PHARMA HOLDINGS, INC. REPORTS THIRD QUARTER 2019
FINANCIAL
RESULTS
* Q3 LOSS PER SHARE $0.02
* Q3 REVENUE ROSE 3.4 PERCENT TO $2.4 MILLION
* CHINA PHARMA- FACED NEGATIVE EFFECTS ON SALES FROM
IMPLEMENTATION OF GOVERNMENT POLICY TO CONTROL SPENDING
PROPORTION ON DRUGS TO PATIENTS' EXPENSES
* CHINA PHARMA- FACED PRESSURE FROM STRINGENT REQUIREMENTS
OF DRUG
REGISTRATION STANDARDS, CONSISTENCY EVALUATIONS
* CHINA PHARMA- WILL FURTHER EVALUATE MARKET CONDITIONS FOR
CURRENT EXISTING PRODUCTS, PIPELINE PRODUCTS, AND COMPETITION IN
THE MARKET
Source text for Eikon: ID:nPn8FKJ2qa
Further company coverage: CPHI.A
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split